Skip to search formSkip to main contentSkip to account menu

Risedronate

Known as: Risedronsäure, RISE, 1-Hydroxy-2-(3-pyridyl)ethylidene diphosphonate 
A synthetic pyridinyl bisphosphonate agent. Risedronate binds to hydroxyapatite crystals in bone and inhibits osteoclast-dependent bone resorption… 
National Institutes of Health

Related topics

Related topics

12 relations

Narrower (4)

ActonelNE 58095risedronate sodiumrisedronate sodium 30 MG Oral Tablet
DiphosphonatesDrug AllergyEsophageal AchalasiaHypocalcemia

Broader (1)

risedronic acid

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Effects of Risedronate on Alveolar Bone Loss and Angiogenesis: A Stereologic Study in Rats
Background: The present study was designed to evaluate the effects of risedronate, one of the most potent bisphosphonates, on… 
2007
2007
The aminobisphosphonate risedronate preserves localized mineral and material properties of bone in the presence of glucocorticoids.
OBJECTIVE Glucocorticoids (GCs) alter bone strength such that patients receiving these medications have a high rate of fragility… 
Highly Cited
2006
Highly Cited
2006
Solid-state NMR, crystallographic, and computational investigation of bisphosphonates and farnesyl diphosphate synthase-bisphosphonate complexes.
Bisphosphonates are a class of molecules in widespread use in treating bone resorption diseases and are also of interest as… 
2005
2005
Periodontal assessment of postmenopausal women receiving risedronate
Objective:The purpose of this study was to compare periodontal status of postmenopausal women with mild to moderate osteoporosis… 
2003
2003
Clinical trial of risedronate in Japanese volunteers: single and multiple oral dose studies
The tolerability and pharmacokinetics of risedronate after a single oral administration and during multiple oral administrations… 
2003
2003
Pharmacoeconomic analysis of osteoporosis treatment with risedronate.
Hip fracture is an important and costly problem. Therapy with the bisphosphonate risedronate effectively prevents hip and other… 
Highly Cited
2002
Highly Cited
2002
A Comparison of the Effect of Risedronate and Etidronate on Lumbar Bone Mineral Density in Japanese Patients with Osteoporosis: A Randomized Controlled Trial
Abstract: To demonstrate the clinical benefit of 2.5 mg daily risedronate in the treatment of involutional osteoporosis, the… 
2002
2002
Assessment of mortality in patients enrolled in a risedronate clinical trial program: a retrospective cohort study.
Risedronate, a pyridinyl bisphosphonate, has been shown in large clinical trials to be effective in the prevention and treatment… 
2000
2000
Gastric damage in the rat with nitrogen‐containing bisphosphonates depends on pH
The use of nitrogen‐containing bisphosphonates (N‐BPs) has been reported to be associated with gastrointestinal intolerance. The… 
1998
1998
Risedronate Gastrointestinal Absorption Is Independent of Site and Rate of Administration
AbstractPurpose. Two studies were conducted to compare the absorption of risedronate administered as a solution to three… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)